Advertisement

Does Neurocrine, The No. 1 Biotech Stock, Have The Next Ketamine On Its Hands?

Does Neurocrine, The No. 1 Biotech Stock, Have The Next Ketamine On Its Hands?

Top-notch biotech stock Neurocrine surged Tuesday after analysts suggested the company's depression treatment could rival ketamine.